Business Description
Anxo Pharmaceutical Co Ltd
ISIN : TW0006677008
Share Class Description:
ROCO:6677: Ordinary SharesTotal Employee Number:
307Description
Anxo Pharmaceutical Co Ltd is a drug manufacturer. The company is engaged in developing drugs which include prescription medication and consumer healthcare medication. The products of the company include cardiovascular system medication, central nervous system medication, diabetes medication, infectious medicine, and dermatology medication.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.53 | |||||
Equity-to-Asset | 0.48 | |||||
Debt-to-Equity | 0.74 | |||||
Debt-to-EBITDA | 15.56 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 1.13 | |||||
Beneish M-Score | -2.78 | |||||
WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -5.7 | |||||
3-Year EBITDA Growth Rate | -21.7 | |||||
3-Year EPS without NRI Growth Rate | -32.8 | |||||
3-Year FCF Growth Rate | -54.6 | |||||
3-Year Book Growth Rate | 6.9 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 46.13 | |||||
9-Day RSI | 49.08 | |||||
14-Day RSI | 48.53 | |||||
3-1 Month Momentum % | -9.31 | |||||
6-1 Month Momentum % | -15.17 | |||||
12-1 Month Momentum % | -3.4 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.57 | |||||
Quick Ratio | 1.1 | |||||
Cash Ratio | 0.72 | |||||
Days Inventory | 174.78 | |||||
Days Sales Outstanding | 76.03 | |||||
Days Payable | 42.31 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -3.9 | |||||
Shareholder Yield % | 0.07 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 35.6 | |||||
Operating Margin % | -5.09 | |||||
Net Margin % | -4.05 | |||||
EBITDA Margin % | 5.6 | |||||
FCF Margin % | 0.7 | |||||
OCF Margin % | 6.56 | |||||
ROE % | -3.39 | |||||
ROA % | -1.64 | |||||
ROIC % | -2.12 | |||||
3-Year ROIIC % | -111.2 | |||||
ROC (Joel Greenblatt) % | -2.26 | |||||
ROCE % | -1.85 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Price-to-Owner-Earnings | 44.4 | |||||
PS Ratio | 1.14 | |||||
PB Ratio | 0.97 | |||||
Price-to-Tangible-Book | 1.02 | |||||
Price-to-Free-Cash-Flow | 162.27 | |||||
Price-to-Operating-Cash-Flow | 17.38 | |||||
EV-to-EBIT | -49.27 | |||||
EV-to-EBITDA | 30.21 | |||||
EV-to-Revenue | 1.69 | |||||
EV-to-FCF | 242.77 | |||||
Price-to-GF-Value | 0.57 | |||||
Price-to-Projected-FCF | 0.93 | |||||
Earnings Yield (Greenblatt) % | -2.03 | |||||
FCF Yield % | 0.61 | |||||
Forward Rate of Return (Yacktman) % | -21.59 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Anxo Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 843.263 | ||
| EPS (TTM) (NT$) | -0.61 | ||
| Beta | -0.0559 | ||
| 3-Year Sharpe Ratio | -1.41 | ||
| 3-Year Sortino Ratio | -1.5 | ||
| Volatility % | 37.97 | ||
| 14-Day RSI | 48.53 | ||
| 14-Day ATR (NT$) | 0.488689 | ||
| 20-Day SMA (NT$) | 17.085 | ||
| 12-1 Month Momentum % | -3.4 | ||
| 52-Week Range (NT$) | 16.35 - 30.5 | ||
| Shares Outstanding (Mil) | 55.98 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Anxo Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Anxo Pharmaceutical Co Ltd Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| TWD 0.398975 Cash Dividend | 2024-08-26 | 35.20 (+0.72%) | ||
| 1.05:1 Stock Split | 2021-11-01 | 22.23 (-0.21%) | ||
| 1.03:1 Stock Split | 2019-07-15 | 31.36 (+0.00%) |
Show
Entries
Anxo Pharmaceutical Co Ltd Frequently Asked Questions
What is Anxo Pharmaceutical Co Ltd(ROCO:6677)'s stock price today?
The current price of ROCO:6677 is NT$17.20. The 52 week high of ROCO:6677 is NT$30.50 and 52 week low is NT$16.35.
When is next earnings date of Anxo Pharmaceutical Co Ltd(ROCO:6677)?
The next earnings date of Anxo Pharmaceutical Co Ltd(ROCO:6677) is .
Does Anxo Pharmaceutical Co Ltd(ROCO:6677) pay dividends? If so, how much?
Anxo Pharmaceutical Co Ltd(ROCO:6677) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Anxo Pharmaceutical Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers